A recent Small Caps article discussed the latest acquisition in the pharmaceutical packaging world. Australia-based pharmaceutical company Probiotec has agreed to pay $23 million for Australian Blister Sealing (ABS) with an additional $5 million cash bonus if specific revenue hurdles are cleared in the first year. ABS offers a wide range of services including foil and blister packing, bottle filling, labeling, and secondary packaging of pharmaceutical and consumer products. The acquisition will likely close in the first quarter of the 2020 financial year, with forecast revenues expected to exceed $100 million by year-end.
Probiotec Acquires Pharmaceutical Packager Australian Blister Sealing
Pharmaceutical company Probiotec has agreed to pay at least $23 million to acquire all issued shares of ABS.
Jul 5, 2019
How to Honor a Leader
Induction into the Packaging & Processing Hall of Fame is the highest honor in our industry. Submit your leader to be considered for the Class of 2024 now through June 10th. New members will be inducted at PACK EXPO International in Chicago.
Read More